{"id":"https://openalex.org/W1967658581","doi":"https://doi.org/10.1002/1097-0142(19841115)54:10<2262::aid-cncr2820541033>3.0.co;2-n","title":"In vitro and in vivo studies on potentiation of cytotoxic effects of anticancer drugs or cobalt 60 gamma ray by interferon on human neoplastic cells","display_name":"In vitro and in vivo studies on potentiation of cytotoxic effects of anticancer drugs or cobalt 60 gamma ray by interferon on human neoplastic cells","publication_year":1984,"publication_date":"1984-11-15","ids":{"openalex":"https://openalex.org/W1967658581","doi":"https://doi.org/10.1002/1097-0142(19841115)54:10<2262::aid-cncr2820541033>3.0.co;2-n","mag":"1967658581","pmid":"https://pubmed.ncbi.nlm.nih.gov/6207909"},"language":"en","primary_location":{"id":"doi:10.1002/1097-0142(19841115)54:10<2262::aid-cncr2820541033>3.0.co;2-n","doi":"https://doi.org/10.1002/1097-0142(19841115)54:10<2262::aid-cncr2820541033>3.0.co;2-n","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(19841115)54:10<2262::aid-cncr2820541033>3.0.co;2-n","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109173342","display_name":"Masayoshi Namba","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Masayoshi Namba","raw_affiliation_strings":["Departments of Pathology, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pathology, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037835293","display_name":"Shoichi Yamamoto","orcid":"https://orcid.org/0000-0003-4833-5216","observed_orcids":["https://orcid.org/0000-0003-4833-5216"]},"institutions":[{"id":"https://openalex.org/I189996419","display_name":"Kawasaki Medical School","ror":"https://ror.org/059z11218","country_code":"JP","type":"education","lineage":["https://openalex.org/I189996419"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shoichi Yamamoto","raw_affiliation_strings":["Urology of Kawasaki Medical School, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urology of Kawasaki Medical School, Kurashiki, Japan","institution_ids":["https://openalex.org/I189996419"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056921218","display_name":"Hiroyoshi Y. Tanaka","orcid":"https://orcid.org/0000-0003-1494-7716","observed_orcids":["https://orcid.org/0000-0003-1494-7716"]},"institutions":[{"id":"https://openalex.org/I189996419","display_name":"Kawasaki Medical School","ror":"https://ror.org/059z11218","country_code":"JP","type":"education","lineage":["https://openalex.org/I189996419"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroyoshi Tanaka","raw_affiliation_strings":["Urology of Kawasaki Medical School, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urology of Kawasaki Medical School, Kurashiki, Japan","institution_ids":["https://openalex.org/I189996419"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111794545","display_name":"Toshinori Kanamori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165085132","display_name":"Mochida Pharmaceutical (Japan)","ror":"https://ror.org/045p8e908","country_code":"JP","type":"company","lineage":["https://openalex.org/I165085132"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshinori Kanamori","raw_affiliation_strings":["Mochida Pharmaceutical Co., Ltd., Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mochida Pharmaceutical Co., Ltd., Tokyo","institution_ids":["https://openalex.org/I165085132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074546199","display_name":"Masahiro Nobuhara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165085132","display_name":"Mochida Pharmaceutical (Japan)","ror":"https://ror.org/045p8e908","country_code":"JP","type":"company","lineage":["https://openalex.org/I165085132"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Nobuhara","raw_affiliation_strings":["Mochida Pharmaceutical Co., Ltd., Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mochida Pharmaceutical Co., Ltd., Tokyo","institution_ids":["https://openalex.org/I165085132"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111958748","display_name":"Tetsuo Kimoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tetsuo Kimoto","raw_affiliation_strings":["Departments of Pathology, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pathology, Kurashiki, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109173342"],"corresponding_institution_ids":[],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.7402,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.8500675,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"54","issue":"10","first_page":"2262","last_page":"2267"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.008100000210106373,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.906000018119812},{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.621999979019165},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.722000002861023},{"id":"https://openalex.org/keywords/60co-gamma-irradiation","display_name":"cobalt-60 gamma rays","score":0.8669999837875366},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.8410000205039978},{"id":"https://openalex.org/keywords/cytotoxicity-potentiation","display_name":"cytotoxicity potentiation","score":0.7990000247955322},{"id":"https://openalex.org/keywords/hela-cells","display_name":"HeLa cells","score":0.7429999709129333},{"id":"https://openalex.org/keywords/peplomycin","display_name":"peplomycin","score":0.8009999990463257},{"id":"https://openalex.org/keywords/bleomycin","display_name":"bleomycin","score":1.0},{"id":"https://openalex.org/keywords/aclacinomycin","display_name":"aclacinomycin","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/combination-cancer-therapy","display_name":"combination cancer therapy","score":0.6930000185966492},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6499999761581421}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6355679631233215},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6288769245147705},{"id":"https://openalex.org/C2776232574","wikidata":"https://www.wikidata.org/wiki/Q415571","display_name":"Bleomycin","level":3,"score":0.6027712821960449},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6009739637374878},{"id":"https://openalex.org/C2777366897","wikidata":"https://www.wikidata.org/wiki/Q847482","display_name":"HeLa","level":3,"score":0.598812460899353},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.5599309802055359},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5284385681152344},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5190554261207581},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5181266665458679},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4602789580821991},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4489330053329468},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2675851583480835},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25652050971984863},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2254592478275299},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18133953213691711},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08955538272857666},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D003037","descriptor_name":"Cobalt Radioisotopes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005720","descriptor_name":"Gamma Rays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011838","descriptor_name":"Radiation-Sensitizing Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/1097-0142(19841115)54:10<2262::aid-cncr2820541033>3.0.co;2-n","doi":"https://doi.org/10.1002/1097-0142(19841115)54:10<2262::aid-cncr2820541033>3.0.co;2-n","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(19841115)54:10<2262::aid-cncr2820541033>3.0.co;2-n","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:6207909","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6207909","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1589608483","https://openalex.org/W1978606578","https://openalex.org/W1995578078","https://openalex.org/W1996549520","https://openalex.org/W1999087217","https://openalex.org/W1999867700","https://openalex.org/W2018162474","https://openalex.org/W2047330128","https://openalex.org/W2084929520","https://openalex.org/W2128053342","https://openalex.org/W2138039307","https://openalex.org/W2169163372","https://openalex.org/W2269595883","https://openalex.org/W3216705818"],"related_works":["https://openalex.org/W1997695098","https://openalex.org/W2084929520","https://openalex.org/W1545320152","https://openalex.org/W22400421","https://openalex.org/W2358539475","https://openalex.org/W2064817827","https://openalex.org/W1629970388","https://openalex.org/W2061397228","https://openalex.org/W2415441855","https://openalex.org/W2414910088"],"abstract_inverted_index":{"A":[0],"possibility":[1,158],"that":[2,159],"interferon":[3,150,173],"may":[4,174],"potentiate":[5],"the":[6,94],"cytotoxic":[7,95],"effects":[8,96,119],"of":[9,66,97,115,120,131,136,149,162,165,179],"anticancer":[10,92,166],"drugs":[11,167],"or":[12,168],"60Co":[13,50,121,169],"gamma":[14,51,122,170],"ray":[15,123,171],"on":[16],"human":[17,31,56,70],"neoplastic":[18,32],"cells":[19,33,59,138],"was":[20,63,74,143],"studied":[21],"by":[22,49,69,76,84,112,127,134,146],"in":[23,26,47,80,177],"vitro":[24,81],"and":[25,40,83,107,151],"vivo":[27],"experimental":[28],"procedures.":[29],"The":[30,72,117,129,153],"used":[34],"were":[35,60,110,124],"HeLa":[36,137],"(uterine":[37],"cervical":[38],"cancer)":[39],"WI-38":[41,58],"CT-1":[42],"(embryonic":[43],"lung":[44],"fibroblasts":[45],"transformed":[46],"culture":[48],"ray)":[52],"cells.":[53],"As":[54],"normal":[55],"cells,":[57],"used.":[61],"Interferon":[62],"a":[64,140,157],"preparation":[65],"beta-type":[67],"produced":[68],"fibroblasts.":[71],"cytotoxicity":[73],"determined":[75],"colony":[77],"formation":[78],"for":[79,87],"experiments":[82],"tumor":[85,132],"growth":[86,130],"animal":[88],"experiments.":[89],"Of":[90],"17":[91],"drugs,":[93,99],"six":[98],"namely,":[100],"peplomycin,":[101],"bleomycin,":[102],"aclacinomycin,":[103],"cisplatin,":[104],"5-fluorouracil":[105],"(5-FU),":[106],"Adriamycin":[108],"(doxorubicin)":[109],"potentiated":[111],"concomitant":[113],"application":[114],"interferon.":[116,128],"cytolethal":[118],"also":[125],"enhanced":[126],"induced":[133],"transplantation":[135],"into":[139],"nude":[141],"mouse":[142],"remarkably":[144],"reduced":[145],"combination":[147],"therapy":[148,161],"5-FU.":[152],"current":[154],"results":[155],"indicate":[156],"combined":[160],"certain":[163],"types":[164],"with":[172],"be":[175],"effective":[176],"treatment":[178],"cancer":[180],"patients.":[181]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}